中药益生元的研究进展
Prebiotics in Chinese materia medica:research progress
邵匡振 1丁向萍 1张子恒 1傅思武1
作者信息
- 1. 西北民族大学医学部,甘肃兰州 730030
- 折叠
摘要
中药是我国传统医学的重要组成部分,具有悠久的历史背景和丰富的临床应用基础.随着现代医学的不断发展,中药在预防和治疗肠道疾病方面显示出独特的优势,但其作用机制尚待阐明.近年来,随着对肠道菌群的深入研究,人们逐渐认识到中药中的有些成分具有益生元的作用,且与传统的益生元相比,具有特殊的药理活性和天然来源的优势.因此,本文就党参、黄芪、人参和枸杞等单体中药以及复方制剂的益生元作用作一综述,以期为中药益生元的研究和临床开发提供参考.
Abstract
Chinese materia medica constitutes a significant component of our country's traditional medical practices,boasting an extensive historical background and rich clinical applications.With the continuous evolution of modem medi-cine,Chinese materia medica has demonstrated unique advantages in both the prevention and treatment of intestinal dis-orders.However,the precise mechanisms of its actions remain to be fully elucidated.In recent years,as a result of in-depth research into the gut microbiota,there has been a gradual recognition that certain components within Chinese materia medica possess prebiotic effects,promoting a healthy gut microbiota.Moreover,these components exhibit distinctive phar-macological activities and originate from natural sources,setting them apart from traditional prebiotics.Hence,this article aims to provide a comprehensive review of the prebiotic effects found in individual components of Chinese materia medica such as Codonopsis pilosula,Astragalus membranaceus,Panax ginseng,Lycium barbarum,and compound formulations.The objective is to serve as a reference for the research and clinical development of prebiotics derived from Chinese mater-ia medica.
关键词
中药/益生元/肠道菌群Key words
Chinese materia medica/Prebiotics/Gut microbiota引用本文复制引用
基金项目
西北民族大学中央高校创新团队项目(31920200025)
出版年
2024
NETL
NSTL
万方数据